$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
阿那莫林(Anamorelin)详细说明书:适应症、用法用量、副作用、注意事项
2025-10-19 11:44:20
Check Details
二甲双胍增强癌细胞对化疗敏感性
2025-10-19 11:44:20
Check Details
阴道袖带近距离放射治疗子宫内膜癌具有低毒性
2025-10-19 11:44:20
Check Details
疗效显著:塞利尼索显著改善晚期或复发性子宫内膜癌的无进展生存期
2025-10-19 11:44:20
Check Details
度伐利尤单抗(Imfinzi)的中文说明书
2025-10-19 11:44:20
Check Details
治疗鼻咽癌的低毒性选择:奈达铂化疗
2025-10-19 11:44:20
Check Details
FDA批准阿维鲁单抗(Avelumab)用于转移性默克尔细胞癌、晚期或转移性尿路上皮癌以及与阿西替尼联合用于晚期肾细胞癌的治疗
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)用法用量:推荐剂量,剂量调整、不良反应剂量调整
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)的不良反应和副作用
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)详细说明书
2025-10-19 11:44:20
Check Details
阿维鲁单抗(Avelumab)中文说明书:适应症、用法用量、不良反应、注意事项
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼对胶质瘤亚型有良好疗效
2025-10-19 11:44:20
Check Details
1
2
...
6095
6096
6097
6098
6099
6100
6101
...
10232
10233
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
2
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
3
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
4
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy
5
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
6
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
7
Fezolinetant (Veozah) Dosing and Liver Monitoring Guide
8
Lusutrombopag Safety and Dosing: Thrombosis Risk and Indications
9
Mirogabalin for Neuropathic Pain: Onset Time and Dosing Strategy
10
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
11
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments
12
Anagrelide and Myelofibrosis Risk: Controversy and Monitoring in ET Treatment